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NNIN Facility utilized: Characterization Facility
To investigate the biodistribution of the components (Au and TNF-α) of a nanodrug -CYT-6091 in an in vivo model system.
Au (drug-carrier) was observed by Transmission Electron Microscopy. TNF-α (drug) was measured by ELISA.
Publications Goel et al., 2008 , ASME Bioengineering Conference.
MAJOR OBSERVATIONS
The drug, TNF-α, was observed to accumulate selectively in the tumor tissue. The carrier, Au, was observed to be present as individual particles in tumor and as clusters in liver and spleen. 
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